Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Physiomics ( (GB:PYC) ) has provided an update.
Physiomics plc has successfully completed a £430,000 placing to fund growth opportunities, issuing 86,000,000 new ordinary shares at a 37.5% discount. The company is also launching a retail offer to raise an additional £70,000. The funds will support the recruitment of technical staff, business development, and strategic growth in their consulting services. The company has made progress with new contract awards and publications, and aims to further its personalized medicine tools in collaboration with DoseMe. Recent achievements include contract wins and high-profile collaborations, positioning the company for continued growth and new business opportunities in the biotech and pharma sectors.
More about Physiomics
Physiomics plc is a leading company in the mathematical modelling and data science industry, primarily supporting the development of new therapeutics and personalized medicine solutions. They utilize cutting-edge PKPD and QSP modelling, along with data science techniques and deep biology expertise, to aid biotech and pharma companies in optimizing drug development, reducing risks, and enhancing research design across various stages of drug discovery and development.
YTD Price Performance: 6.67%
Average Trading Volume: 4,104,525
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £1.73M
For an in-depth examination of PYC stock, go to TipRanks’ Stock Analysis page.
